GSK Secures Zofran MDL Victory: Cost Recovery Granted
TL/DR –
GlaxoSmithKline and its legal team from Shook Hardy & Bacon LLP are to receive over $450,000 in legal costs after successfully defending a multidistrict lawsuit. The suit alleged that GlaxoSmithKline’s anti-nausea drug, Zofran, was responsible for causing birth defects. A federal judge ruled in favor of the pharmaceutical company.
GlaxoSmithKline Granted Legal Costs Recovery in Zofran Lawsuit
In a recent turn of events, pharmaceutical giant GlaxoSmithKline, along with its lawyers from Shook Hardy & Bacon LLP, has been allowed to recover over $450,000 in legal fees. This follows their victory in a multidistrict lawsuit concerning the company’s anti-nausea drug Zofran. The drug was alleged to cause birth defects, a claim GlaxoSmithKline successfully defended against.
Stay informed about the latest in legal trends, issues, and developments with a Law360 subscription. Subscribers gain access to over 60 topics across various industries and jurisdictions, with over 200 articles published daily.
Law360 Subscription Benefits
Subscribers to Law360 enjoy numerous benefits, such as:
- Access to daily newsletters
- Expert analysis on various topics
- Use of the mobile app for anywhere, anytime access
- Advanced search functionality
- Updates on judge information
- Real-time alerts for current events
- An archive of over 450,000 searchable articles
Experience the wealth of information available on Law360 with a free 7-day trial. Sign up today and stay ahead in the legal world.
—
Read More Health & Wellness News ; US News